France Grants Reimbursed Compassionate Access for BOT/BAL in Refractory MSS Colorectal Cancer

BOT/BAL-in-MSS CRC

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology

SIOG and OncoDaily Announce Strategic Partnership to Advance Global Geriatric Oncology

SIOG

35 posts not to miss from WCLC24 Day 4

WCLC24

NIH Launches a New Initiative to Create a 21st Century Biosafety Framework

NIH Launches a New Initiative to Create a 21st Century Biosafety Framework

Global Leaders in Cancer Research Join OncoDaily’s Editorial Board

Cancer research

Top Colorectal Cancer Trials to Watch at ESMO 2025

Top Colorectal trials

OncoCalendar

« All Events

  • This event has passed.

SE Asia Course II: Immunotherapy in Lung Cancer By IASLC

December 16, 2024 • 7:00 PM - 9:00 PM
SE Asia Course II: Immunotherapy in Lung Cancer By IASLC

SE Asia Course II: Immunotherapy in Lung Cancer By IASLC will be held on December 16th, 2024.

This exclusive course will offer the latest updates on lung cancer treatment in Southeast Asia, with a special focus on immunotherapy. In Series II, renowned thoracic oncology experts from the region will delve into the role of immunotherapy in revolutionizing lung cancer care. Discussions will cover crucial topics such as the integration of biomarkers for immunotherapy, the best management strategies for advanced disease, and addressing challenges like pneumonitis. Participants will have the opportunity to explore how immunotherapy is set to transform the landscape of lung cancer treatment in Southeast Asia, bringing hope for improved patient outcomes.

See the Speakers and Southeast Asia Team Below:

SE Asia Course II: Immunotherapy in Lung Cancer By IASLC

Details

Date:
December 16, 2024
Time:
7:00 PM - 9:00 PM
Website:
https://www.iaslc.org/node/35048

Organizer

The International Association for the Study of Lung Cancer (IASLC)
Phone
1-855-464-2752
Email
info@iaslc.org